Salute e Benessere
Wingderm USA Takes the Lead at TAS 2025, Cementing Its Local Presence in the U.S.
The two featured energy-based devices meet the needs of North American practitioners for non-invasive treatments and suitability across diverse skin tones. Both have received FDA clearance, which helps build trust and supports their acceptance in the U.S. market. The FDA clearance not only affirms Wingderm®'s technology, but also lays the foundation for serving clients and building long-term operations in the U.S. market.
Wingderm USA's participation in the show was led by CEO Carol Ren , whose deep understanding of industry trends and Wingderm®'s technologies earned widespread trust. At the booth, she shared in-depth knowledge of the products' features and their clinical applications. Carol said, "The show is just the start. The real value comes from ongoing service. Wingderm USA will act as a strategic hub, linking our headquarters to the U.S. market and providing steady, local support to our clients."
From expanding global distributor network to having its U.S. operations become fully operational, Wingderm® is transforming from brand expansion to building a lasting presence in key markets like
North America . This time, we're not just here—we're here to stay, serve, and support our partners' success.
Wingderm® since its establishment in 2016, with the aim of "Aesthetics & Technology, Easy to Achieve", provides leading and reliable intelligent photoelectric medical aesthetic devices, which have been exported to more than 80 countries, with over 25,000 units installed, recognized for safety and effectiveness by experts and beauty seekers.
For more information, visit: https://www.wingderm.com
Logo - https://mma.prnewswire.com/media/2707091/Wingderm_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/wingderm-usa-takes-the-lead-at-tas-2025-cementing-its-local-presence-in-the-us-302494388.html